As is well known, estrogen plays a protective role in the development of osteoporosis, indirectly inhibiting osteoclast activity through the down-regulation of pro-inflammatory cytokines (IL-1, IL-6, TNF-α, M-CSF) and the up-regulation of TGF-ß, an inhibitor of bone resorption [122]. Here, IL6 is linked to osteoporosis.